---
title: "Chugai Pharmaceutical : Double-digit revenue and profit growth driven by strong sales and robust pipeline progress"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293714128.md"
description: "Revenue and profits saw double-digit growth year-over-year, driven by robust domestic and overseas sales, increased royalty and one-time income, and strong performance in oncology and specialty products. The company maintained high free cash flow and equity ratios, with a positive outlook for the full year.Original document: Chugai Pharmaceutical Co., Ltd. [4519] Interim report — Jul. 24 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-24T07:01:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293714128.md)
  - [en](https://longbridge.com/en/news/293714128.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293714128.md)
generator: "portal-rs"
---

# Chugai Pharmaceutical : Double-digit revenue and profit growth driven by strong sales and robust pipeline progress

Revenue and profits saw double-digit growth year-over-year, driven by robust domestic and overseas sales, increased royalty and one-time income, and strong performance in oncology and specialty products. The company maintained high free cash flow and equity ratios, with a positive outlook for the full year.

Original document: Chugai Pharmaceutical Co., Ltd. \[4519\] Interim report — Jul. 24 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CHGCY.US](https://longbridge.com/en/quote/CHGCY.US.md)
- [4519.JP](https://longbridge.com/en/quote/4519.JP.md)

## Related News & Research

- [Chugai licenses anti-dengue antibody AID351 to GSK in exclusive deal](https://longbridge.com/en/news/296167792.md)
- [Chugai files Japan application for Tecentriq as adjuvant MSI-high colon cancer treatment](https://longbridge.com/en/news/295890880.md)
- [The AI boom has echoes of Enron — but that might be okay, a tech guru says](https://longbridge.com/en/news/296021200.md)
- [Walmart store workers have a new responsibility: correcting AI errors](https://longbridge.com/en/news/296213777.md)
- [Indra says FaRADAI R&D validates explainable AI to assess threats, plot safe routes in military operations](https://longbridge.com/en/news/296213236.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**